Back

Current prevalence and remaining challenges of sodium-glucose cotransporter 2 inhibitors in patients with heart failure

European Heart Journal - Quality of Care and Clinical Outcomes

17 April 2026
Organised by: Logo
Read full article
ESC Journals HEART FAILURE Chronic Heart Failure

Contributors

Akito Nakagawa
Akito Nakagawa

Author

Amagasaki Chuo Hospital Amagasaki , Japan

You may be interested in
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States
22 May 2023
thumbnail
Congress Session
SGLT2 inhibitors in practice (part 2): how do we implement new treatments in HFpEF?
27 August 2022
thumbnail
Congress Session
Breaking the barriers in guideline-directed medical therapy implementation in heart failure
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources